EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Safety of indocyanine green for lymph node mapping in early-stage vulvar cancer: multicenter evaluation and systematic review

Alberto Rafael Guijarro-Campillo, Pablo Padilla-Iserte, Bárbara Couso, Diego Erasun, Jesús Utrilla-Layna, Octavio Arencibia, Juan Gilabert-Estellés, Nadia Veiga, Ana Boldo-Roda, Víctor Lago, Anibal Nieto, Santiago Domingo und 1 weitere

Archives of Gynecology and Obstetrics · 14.01.2026 · 313 (1)

DOI: 10.1007/s00404-025-08244-8 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 14.01.2026. Verfasst von Alberto Rafael Guijarro-Campillo und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Valencia, Valencia, Spain. alguicam@alumni.uv.es. Hauptthemen laut MEDLINE: Coloring Agents, Drug Hypersensitivity, Indocyanine Green, Sentinel Lymph Node Biopsy. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Valencia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to evaluate the rate and severity of allergic events associated with the use of indocyanine green (ICG) in sentinel lymph node biopsy (SLNB) for patients with early-stage vulvar cancer. The research question focused on whether ICG administration poses a significant risk of allergic reactions, especially in patients with a history of allergies to iodinated contrast.

Methods

We conducted a retrospective study after prospective multicenter recruitment endorsed by the Spanish Investigational Network Gynecologic Oncology Group. Data on patient demographics, history of allergic reactions, and ICG administration were collected. A systematic literature review was performed to assess existing studies on ICG-related allergic reactions in SLNB.

Results

Among the 75 patients, 66 (75%) have been exposed to iodinated contrasts and 2 (3%) had a documented iodinated contrast allergy with a mild reaction. There were no intraoperative complications. During the postoperative period, there were only minor complications (15 (20.0%) grade I and 13 (17.3%) grade II of Clavien–Dindo classification), and none associated with the injection of ICG or allergen-based that could be related. The systematic review of 11 studies involved 206 patients and 354 groins. The history of allergy to iodinated contrast was not recorded in any of them. We observed no patients with adverse reactions related to this tracer after peritumoral injection.

Conclusion

Our findings suggest that peritumoral ICG injection for SLNB in early-stage vulvar cancer could be safe. This study reinforces the potential for ICG to be a reliable tracer in vulvar cancer staging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coloring AgentsDrug HypersensitivityIndocyanine GreenSentinel Lymph Node BiopsyVulvar NeoplasmsAdultAgedAged, 80 and overFemaleHumansMiddle AgedContrast MediaNeoplasm StagingRetrospective StudiesMulticenter Studies as Topic

Stichwörter der Autor:innen

Allergic reactionsIndocyanine greenSentinel lymph node biopsyVulvar cancer

Substanzen

Coloring AgentsContrast MediaIndocyanine Green

Autor:innen und Institutionen

  • University of Valencia, Valencia, Spain. alguicam@alumni.uv.es.
  • University of Valencia, Valencia, Spain.
  • Department of Gynecologic Oncology, University and Polytechnic Hospital of La Fe, Valencia, Spain.
  • Department of Obstetrics and Gynecology, University General Hospital of Valencia, University of Valencia, Valencia, Spain.
  • Department of Obstetrics and Gynecology, University Hospital of Ourense, Ourense, Spain.
  • Department of Obstetrics and Gynecology, Hospital Marqués de Valdecilla, Santander, Spain.

Förderung

  • Universitat de Valencia

Zitieren

APA

Guijarro-Campillo, A. R., Padilla-Iserte, P., Couso, B., Erasun, D., Utrilla-Layna, J., Arencibia, O., Gilabert-Estellés, J., Veiga, N., Boldo-Roda, A., Lago, V., Nieto, A., Domingo, S., & SEGO Spain-GOG Group (2026). Safety of indocyanine green for lymph node mapping in early-stage vulvar cancer: multicenter evaluation and systematic review. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-025-08244-8

Vancouver

Guijarro-Campillo AR, Padilla-Iserte P, Couso B, Erasun D, Utrilla-Layna J, Arencibia O, et al. Safety of indocyanine green for lymph node mapping in early-stage vulvar cancer: multicenter evaluation and systematic review. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-025-08244-8

BibTeX
@article{GuijarroCampillo2026,
  author = {Guijarro-Campillo, Alberto Rafael and Padilla-Iserte, Pablo and Couso, Bárbara and Erasun, Diego and Utrilla-Layna, Jesús and Arencibia, Octavio and Gilabert-Estellés, Juan and Veiga, Nadia and Boldo-Roda, Ana and Lago, Víctor and Nieto, Anibal and Domingo, Santiago and SEGO Spain-GOG Group, SEGO Spain-GOG Group},
  title = {Safety of indocyanine green for lymph node mapping in early-stage vulvar cancer: multicenter evaluation and systematic review},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2026},
  volume = {313},
  number = {1},
  doi = {10.1007/s00404-025-08244-8}
}
Kostenlos starten →